Capital World Investors Sells 343,389 Shares of The Cooper Companies, Inc. $COO

Capital World Investors reduced its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 3.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,208,203 shares of the medical device company’s stock after selling 343,389 shares during the period. Capital World Investors owned approximately 0.05% of Cooper Companies worth $836,664,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in COO. Capital International Inc. CA raised its holdings in shares of Cooper Companies by 22.9% during the 4th quarter. Capital International Inc. CA now owns 118,210 shares of the medical device company’s stock worth $9,688,000 after buying an additional 22,054 shares in the last quarter. Los Angeles Capital Management LLC acquired a new stake in Cooper Companies in the fourth quarter valued at about $75,000. Havemeyer Place LP acquired a new stake in Cooper Companies in the fourth quarter valued at about $2,429,000. Parallel Advisors LLC grew its position in Cooper Companies by 72.8% in the fourth quarter. Parallel Advisors LLC now owns 1,583 shares of the medical device company’s stock valued at $130,000 after acquiring an additional 667 shares during the last quarter. Finally, TruNorth Capital Management LLC bought a new position in Cooper Companies in the fourth quarter valued at about $265,000. 24.39% of the stock is currently owned by institutional investors.

Key Cooper Companies News

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Cooper Companies posted better-than-expected Q2 results, with EPS of $1.21 topping estimates of $1.10 and revenue of $1.08 billion beating forecasts, while sales rose 7.9% year over year. CooperCompanies Announces Second Quarter 2026 Results
• Positive Sentiment: Management said it reached agreements to resolve substantially all claims tied to the prior fertility media recall, reducing a major legal overhang and supporting investor confidence in the company’s outlook. QuiverQuant article
• Positive Sentiment: Needham reaffirmed a Buy rating on COO and lowered its price target to $86, still implying meaningful upside from current levels. TipRanks analyst update
• Positive Sentiment: Stifel, Baird, and JPMorgan all cut price targets but kept constructive ratings, suggesting analysts see the report as solid even after valuation resets. Benzinga analyst update
• Neutral Sentiment: The company guided FY2026 EPS to $4.58-$4.66, slightly around consensus, which helps confirm expectations but does not point to a major near-term surprise. Earnings report transcript
• Negative Sentiment: JPMorgan lowered its price target on COO from $80 to $71 and kept a Neutral rating, reflecting more cautious expectations despite the stock’s recent strength. JPMorgan price target update

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. The Goldman Sachs Group set a $61.00 target price on shares of Cooper Companies in a report on Wednesday, May 27th. Needham & Company LLC lowered their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday. Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the company an “overweight” rating in a research note on Monday, June 1st. Citigroup restated a “neutral” rating and issued a $69.00 target price (down from $80.00) on shares of Cooper Companies in a research report on Thursday, May 28th. Finally, KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a research note on Friday. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Hold” and a consensus price target of $82.64.

Cooper Companies Stock Performance

COO opened at $67.34 on Monday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The company’s 50 day moving average price is $65.09 and its two-hundred day moving average price is $74.54. The firm has a market capitalization of $13.14 billion, a price-to-earnings ratio of 57.07, a PEG ratio of 1.73 and a beta of 0.88.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, research analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.